Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Moxiclav Tablets 625mg°


Contraindicated
Risk of necrotizing enterocolitis in newborns

May be acceptable
Moxiclav Tablets 625mg° :
Type Medicine Withdrawn
Originator Augmentin TID Tablets 625mg
Agent C. Catafago & Co
Distributor C. Catafago & Co
Laboratory Medochemie
Manufacturer Medochemie Ltd
Manufacturing Type G
Origin Cyprus
ATC J01CR02

Your comment will appear shortly after approval

Moxiclav Tablets 625mg° :

Revision Date : 29/07/2015


Effect Frequency
Acute generalised exanthematous pustulosis (AGEP) Not known
Agranulocytosis Not known
ALT increased Uncommon
Anaphylaxis Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Antibiotic associated colitis Not known
AST increased Uncommon
Black hairy tongue Not known
Bleeding time prolonged Not known
Cephalea Uncommon
Convulsion Not known
Crystalluria Not known
Dermatitis bullous Not known
Dermatitis exfoliative Not known
Diarrhoea (Diarrhea) Very Common
Erythema multiforme Rare
Haemolytic anemia Not known
Hepatitis Not known
Hyperactivity (Increased activity) Not known
Indigestion Uncommon
Interstitial nephritis Not known
Jaundice cholestatic (Cholestatic icterus) Not known
Leucopenia (Leukopenia) Rare
Lightheadedness Uncommon
Meningitis aseptic Not known
Mucocutaneous candidiasis Common
Nausea Common
Necrolysis epidermal Not known
Neutropenia Rare
Overgrowth of non-susceptible organisms Not known
Pruritus Uncommon
Quick's value increased Not known
Serum sickness Not known
Skin Eruption Uncommon
Stevens-Johnson syndrome Not known
Thrombocytopenia (Thrombopenia) Rare
Urticaria Uncommon
Vasculitides Not known
Vomiting Common

Different Units By MoH Code

Moxiclav Tablets 625mg°  MoH 3445 :
Form Tablet
Package Size Box of 16
Strength 625mg
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 01/01/2000
Registration Year 2000
Withdrawn Date 2003


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info